Form 4: Organon & Co. Director Helene D. Gayle Reports Phantom Stock Transaction

Director Helene D. Gayle reports acquisition of phantom stock units in Organon & Co. through a non-employee director savings plan.

Summary

• Helene D. Gayle, a director of Organon & Co., filed a Form 4 reporting a transaction involving phantom stock.
• On June 7, 2024, Gayle acquired 9,638.554 phantom stock units under the Organon Non-Employee Director Savings Plan.
• These units are economically equivalent to shares of Organon common stock and are payable in cash upon termination of service as a director.
• The price of the phantom stock was $20.75.
• Following the reported transaction, Gayle beneficially owns 36,454.817 derivative securities.
• Holdings include phantom stock acquired in dividend reinvestment transactions on June 15, 2023, September 14, 2023, December 14, 2023 and March 14, 2024.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's securities, providing transparency to investors.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.

Key Dates